Psychemedics Corp
NASDAQ:PMD
Intrinsic Value
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. [ Read More ]
The intrinsic value of one PMD stock under the Base Case scenario is 4.5 USD. Compared to the current market price of 2.55 USD, Psychemedics Corp is Undervalued by 43%.
Valuation Backtest
Psychemedics Corp
Run backtest to discover the historical profit from buying and selling PMD stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Psychemedics Corp
Current Assets | 6.8m |
Cash & Short-Term Investments | 2m |
Receivables | 3.7m |
Other Current Assets | 1.1m |
Non-Current Assets | 5.5m |
PP&E | 4.9m |
Other Non-Current Assets | 632k |
Current Liabilities | 4.7m |
Accounts Payable | 752k |
Accrued Liabilities | 3.7m |
Other Current Liabilities | 305k |
Non-Current Liabilities | 945k |
Other Non-Current Liabilities | 945k |
Earnings Waterfall
Psychemedics Corp
Revenue
|
22.1m
USD
|
Cost of Revenue
|
-13.7m
USD
|
Gross Profit
|
8.4m
USD
|
Operating Expenses
|
-11.3m
USD
|
Operating Income
|
-2.9m
USD
|
Other Expenses
|
-1.2m
USD
|
Net Income
|
-4.2m
USD
|
Free Cash Flow Analysis
Psychemedics Corp
PMD Profitability Score
Profitability Due Diligence
Psychemedics Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
Score
Psychemedics Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
PMD Solvency Score
Solvency Due Diligence
Psychemedics Corp's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Score
Psychemedics Corp's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PMD Price Targets Summary
Psychemedics Corp
Ownership
PMD Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
PMD Price
Psychemedics Corp
Average Annual Return | -12.02% |
Standard Deviation of Annual Returns | 36.16% |
Max Drawdown | -79% |
Market Capitalization | 14.8m USD |
Shares Outstanding | 5 805 610 |
Percentage of Shares Shorted | 0.31% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. The company is headquartered in Acton, Massachusetts and currently employs 139 full-time employees. The firm provides testing services for the detection of drugs of abuse through the analysis of hair samples. The Company’s testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The firm customize its enzyme immunoassay (EIA) procedures to drug test hair samples. The firm provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines, opiates, synthetic cannabinoids, benzodiazepines, nicotine and fentanyl. The firm markets its corporate drug testing services through its own sales force, distributors and webinars. The firm markets its home drug testing service, PDT-90, through the Internet.
Contact
IPO
Employees
Officers
The intrinsic value of one PMD stock under the Base Case scenario is 4.5 USD.
Compared to the current market price of 2.55 USD, Psychemedics Corp is Undervalued by 43%.